Matches in SemOpenAlex for { <https://semopenalex.org/work/W4328010752> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- W4328010752 endingPage "96" @default.
- W4328010752 startingPage "87" @default.
- W4328010752 abstract "It is a known fact that the presence of a chronic disease or chronic pain syndrome reduces the quality of life (QoL). Despite considerable achievements in the diagnostics and treatment of systemic lupus erythematosus (SLE) over the past decades and improvements in the long-term prognosis of patients, many challenges remain unsolved. The investigation of the quality of life can help to comprehensively evaluate patients' health, the effectiveness and safety of treatment and identify other causes of reduced quality of life that are not directly related to the disease.
 Aim of the academic paper lies in evaluating quality of life parameters using the SF-36 questionnaire in patients with SLE and analyzing risk factors for its reduction.
 Materials and Methods. A questionnaire was conducted using the Medical Outcomes Study Short Form 36 questionnaire (SF-36) of 36 patients with systemic lupus erythematosus aged 18 to 62 years, regardless of disease activity at the time of examination, and 24 practically healthy persons, comparable in age and gender ratio. The main parameters of the quality of life in the 2 groups were compared, as well as their dependence on clinical manifestations and therapy was studied.
 Results and Dyscussion. Physical well-being in patients with SLE (29.6±2.97) is significantly lower (p<0.001) than in healthy individuals (55.8±3.31). The level of mental well-being does not differ significantly, but its components, such as social functioning (p=0.047) and vital activity (p=0.01) are reduced in patients with SLE. The level of physical well-being is lower in the groups of patients with the presence of arthritis (p=0.026), avascular necrosis of the femoral head before surgery (p=0.019) and skin rash (p=0.032) in the clinical picture compared to patients without these manifestations. The use of cyclophosphamide (p=0.046) and mycophenolate mofetil (p=0.012) is associated with a higher level of mental well-being.
 Conclusions. Patients with SLE have a lower level of quality of life compared to healthy individuals of the corresponding age and gender. The risk factors for reducing the level of physical well-being are the presence of arthritis, skin rash and avascular necrosis of the femoral head (prior to surgical intervention). The level of mental well-being is significantly higher among patients taking cyclophosphamide and/or mycophenolate mofetil.
 Abbreviations:
 ACR - American College of Rheumatology
 AIDS - acquired immunodeficiency syndrome
 ANFH - avascular necrosis of femoral head
 CF - Cyclophosphamide
 EULAR - The European Alliance of Associations for Rheumatology
 GC - glucocorticoids
 MMF - Mycophenolate mofetil
 SLE - systemic lupus erythematosus
 SLICC - The Systemic Lupus Erythematosus International Collaborating Clinics
 QoL - Quality of life" @default.
- W4328010752 created "2023-03-22" @default.
- W4328010752 creator A5015059570 @default.
- W4328010752 date "2022-12-30" @default.
- W4328010752 modified "2023-09-30" @default.
- W4328010752 title "RISK FACTORS OF LIFE QUALITY REDUCTION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS" @default.
- W4328010752 cites W1982714829 @default.
- W4328010752 cites W2101840106 @default.
- W4328010752 cites W2114332193 @default.
- W4328010752 cites W2114638396 @default.
- W4328010752 cites W2171640388 @default.
- W4328010752 cites W2298285162 @default.
- W4328010752 cites W2305517444 @default.
- W4328010752 cites W2796203049 @default.
- W4328010752 cites W2797968753 @default.
- W4328010752 cites W2810775581 @default.
- W4328010752 cites W2927871970 @default.
- W4328010752 cites W3111741703 @default.
- W4328010752 doi "https://doi.org/10.25040/aml2022.3-4.087" @default.
- W4328010752 hasPublicationYear "2022" @default.
- W4328010752 type Work @default.
- W4328010752 citedByCount "0" @default.
- W4328010752 crossrefType "journal-article" @default.
- W4328010752 hasAuthorship W4328010752A5015059570 @default.
- W4328010752 hasBestOaLocation W43280107521 @default.
- W4328010752 hasConcept C126322002 @default.
- W4328010752 hasConcept C159110408 @default.
- W4328010752 hasConcept C1862650 @default.
- W4328010752 hasConcept C2776912625 @default.
- W4328010752 hasConcept C2779134260 @default.
- W4328010752 hasConcept C2779951463 @default.
- W4328010752 hasConcept C71924100 @default.
- W4328010752 hasConceptScore W4328010752C126322002 @default.
- W4328010752 hasConceptScore W4328010752C159110408 @default.
- W4328010752 hasConceptScore W4328010752C1862650 @default.
- W4328010752 hasConceptScore W4328010752C2776912625 @default.
- W4328010752 hasConceptScore W4328010752C2779134260 @default.
- W4328010752 hasConceptScore W4328010752C2779951463 @default.
- W4328010752 hasConceptScore W4328010752C71924100 @default.
- W4328010752 hasIssue "3-4" @default.
- W4328010752 hasLocation W43280107521 @default.
- W4328010752 hasOpenAccess W4328010752 @default.
- W4328010752 hasPrimaryLocation W43280107521 @default.
- W4328010752 hasRelatedWork W139156958 @default.
- W4328010752 hasRelatedWork W192322703 @default.
- W4328010752 hasRelatedWork W1983984088 @default.
- W4328010752 hasRelatedWork W2136330368 @default.
- W4328010752 hasRelatedWork W2621391523 @default.
- W4328010752 hasRelatedWork W3021551272 @default.
- W4328010752 hasRelatedWork W3176531710 @default.
- W4328010752 hasRelatedWork W4213238193 @default.
- W4328010752 hasRelatedWork W4322703947 @default.
- W4328010752 hasRelatedWork W4225309529 @default.
- W4328010752 hasVolume "28" @default.
- W4328010752 isParatext "false" @default.
- W4328010752 isRetracted "false" @default.
- W4328010752 workType "article" @default.